首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

CANCER SCIENCE
ISSN：1347-9032

CANCER SCIENCE

CANCER SCI
学科领域：医学
是否预警：不在预警名单内
是否OA：是
录用周期：约2.0个月
新锐分区：医学2区
年发文量：327
影响因子：4.3
JCR分区：Q2

基本信息

《癌症科学》（英语：Cancer Science）是日本癌症协会的月刊。该杂志于1907年首次出版，继续发表原创文章、社论和致编辑的信件，描述基础、转化和临床癌症研究领域的原创研究。《癌症科学》杂志也接受报告和病例报告。《癌症科学》杂志旨在提供对肿瘤学家有重大临床影响或可能改变肿瘤疾病概念的高度重要和及时的发现。《华尔街日报》不会发表描述罕见肿瘤或病症的病例报告，除非有新的发现添加到以前的报告中;不同肿瘤的组合，没有新的提示性发现用于肿瘤学研究;已知治疗的显著效果，但没有提示性数据来解释异常结果。也可发表综述文章。
1347-9032SCIE/Scopus收录/DOAJ开放期刊
4.3
点击查看最新影响趋势>
4.7
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：ONCOLOGY
SCIE
Q2
88/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：ONCOLOGY
SCIE
Q1
79/328
129
327
点击查看年发文量趋势图>
9%约62.5%约2.0个月USD2600; GBP1650; EUR2350医学-肿瘤学
2.3%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
87.16%96.48%2.7%
CiteScore：9.30
SJR：1.661
SNIP：1.040
学科类别分区排名百分位
大类：Medicine
小类：Oncology
Q1
60 / 415
大类：Medicine
小类：Cancer Research
Q1
53 / 233

期刊高被引文献

Clinical utility of circulating tumor DNA for colorectal cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.13972
Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.14230
Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma
来源期刊：Cancer ScienceDOI：10.1111/cas.13906
CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells
来源期刊：Cancer ScienceDOI：10.1111/cas.13876
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.13995
Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cells
来源期刊：Cancer ScienceDOI：10.1111/cas.13873
Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.14124
p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild‐type p53
来源期刊：Cancer ScienceDOI：10.1111/cas.13928
Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma
来源期刊：Cancer ScienceDOI：10.1111/cas.14015
ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.13936
Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.13943
Circular RNA hsa_circ_001895 serves as a sponge of microRNA‐296‐5p to promote clear cell renal cell carcinoma progression by regulating SOX12
来源期刊：Cancer ScienceDOI：10.1111/cas.14261
A qualitative transcriptional signature for the early diagnosis of colorectal cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.14137
Lnc-RMRP is involved in the progression of cholangiocarcinoma by regulating miR-217.
来源期刊：Cancer scienceDOI：10.1111/cas.14074
Pattern of cell‐to‐cell transfer of microRNA by gap junction and its effect on the proliferation of glioma cells
来源期刊：Cancer ScienceDOI：10.1111/cas.14029
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.13865
Testis‐specific protein, Y‐linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression
来源期刊：Cancer ScienceDOI：10.1111/cas.13984
Krüppel‐like factor 2 inhibits hepatocarcinogenesis through negative regulation of the Hedgehog pathway
来源期刊：Cancer ScienceDOI：10.1111/cas.13961
Infiltration of tumor‐associated macrophages is involved in tumor programmed death‐ligand 1 expression in early lung adenocarcinoma
来源期刊：Cancer ScienceDOI：10.1111/cas.14272
Cell volume regulation in cancer cell migration driven by osmotic water flow
来源期刊：Cancer ScienceDOI：10.1111/cas.14079
Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations
来源期刊：Cancer ScienceDOI：10.1111/cas.13919
Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.14080
Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.13869
Osteosarcoma‐initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B
来源期刊：Cancer ScienceDOI：10.1111/cas.14229
Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma
来源期刊：Cancer ScienceDOI：10.1111/cas.13909
Tumor‐associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen
来源期刊：Cancer ScienceDOI：10.1111/cas.14078
TP53 alterations in relapsed childhood acute lymphoblastic leukemia
来源期刊：Cancer ScienceDOI：10.1111/cas.14238
Sine oculis homeobox 1 promotes proliferation and migration of human colorectal cancer cells through activation of Wnt/β‐catenin signaling
来源期刊：Cancer ScienceDOI：10.1111/cas.13905
Combination immunotherapy with interleukin‐2 surface‐modified tumor cell vaccine and programmed death receptor‐1 blockade against renal cell carcinoma
来源期刊：Cancer ScienceDOI：10.1111/cas.13842
Glucose starvation induces resistance to metformin through the elevation of mitochondrial multidrug resistance protein 1
来源期刊：Cancer ScienceDOI：10.1111/cas.13952
DNA methylation changes involved in the tumor increase in F2 males born to gestationally arsenite‐exposed F1 male mice
来源期刊：Cancer ScienceDOI：10.1111/cas.14104
UNC5D, suppressed by promoter hypermethylation, inhibits cell metastasis by activating death‐associated protein kinase 1 in prostate cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.13935
Nuclear factor (erythroid‐derived 2)‐like 2 antioxidative response mitigates cytoplasmic radiation‐induced DNA double‐strand breaks
来源期刊：Cancer ScienceDOI：10.1111/cas.13916
Endogenous CXCL9 affects prognosis by regulating tumor‐infiltrating natural killer cells in intrahepatic cholangiocarcinoma
来源期刊：Cancer ScienceDOI：10.1111/cas.14267
Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers
来源期刊：Cancer ScienceDOI：10.1111/cas.14093
Prostaglandin E2 receptor EP4 regulates cell migration through Orai1
来源期刊：Cancer ScienceDOI：10.1111/cas.14247
Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma
来源期刊：Cancer ScienceDOI：10.1111/cas.14215
Mutations found in cell‐free DNAs of patients with malignant lymphoma at remission can derive from clonal hematopoiesis
来源期刊：Cancer ScienceDOI：10.1111/cas.14176
Therapeutic efficacy evaluation of radioimmunotherapy with 90Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma
来源期刊：Cancer ScienceDOI：10.1111/cas.13979
Proposed revision of N categories to the 8th edition of the AJCC‐TNM staging system for non‐surgical esophageal squamous cell cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.13891
Novel strategy of ovarian cancer implantation: Pre‐invasive growth of fibrin‐anchored cells with neovascularization
来源期刊：Cancer ScienceDOI：10.1111/cas.14098
Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma
来源期刊：Cancer ScienceDOI：10.1111/cas.14109
Noncoding RNA transcription at enhancers and genome folding in cancer
来源期刊：Cancer ScienceDOI：10.1111/cas.14107
Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma
来源期刊：Cancer ScienceDOI：10.1111/cas.14178
Cysteine‐rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl‐2 pathway
来源期刊：Cancer ScienceDOI：10.1111/cas.14083
Prognostic value of blood and lymphatic vessel markers in tongue cancer: A systematic review
来源期刊：Cancer ScienceDOI：10.1111/cas.14189
Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study
来源期刊：Cancer ScienceDOI：10.1111/cas.14218
Depletion of DNA damage binding protein 2 sensitizes triple‐negative breast cancer cells to poly ADP‐ribose polymerase inhibition by destabilizing Rad51
来源期刊：Cancer ScienceDOI：10.1111/cas.14201
Female reproductive factors and risk of lymphoid neoplasm: The Japan Public Health Center‐based Prospective Study
来源期刊：Cancer ScienceDOI：10.1111/cas.13962
In this Issue
来源期刊：Cancer ScienceDOI：10.1111/cas.13680

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACADEMIC EMERGENCY MEDICINE封面

ACADEMIC EMERGENCY MEDICINE

学科领域：医学
影响因子：3.2
中科院分区： 2区
ACADEMIC RADIOLOGY封面

ACADEMIC RADIOLOGY

学科领域：医学
影响因子：3.9
中科院分区： 2区
APPETITE封面

APPETITE

学科领域：医学
影响因子：3.8
中科院分区： 2区
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA封面

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

学科领域：医学
影响因子：3.1
中科院分区： 2区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
是
否